These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17046143)
1. Managing the risks of off-licence prescribing in pregnancy. Shah S; van Geijn H Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):156-9. PubMed ID: 17046143 [TBL] [Abstract][Full Text] [Related]
2. A physician's prerogative to prescribe drugs for off-label uses during pregnancy. Rayburn WF Obstet Gynecol; 1993 Jun; 81(6):1052-5. PubMed ID: 8497349 [TBL] [Abstract][Full Text] [Related]
3. Unlicensed and off-label drug use in children: implications for safety. Choonara I Expert Opin Drug Saf; 2004 Mar; 3(2):81-3. PubMed ID: 15006712 [TBL] [Abstract][Full Text] [Related]
4. [Off-label prescribing]. Blondon K; Desmeules J; Vogt-Ferrier N; Besson M; Kondo-Oestreicher M; Dayer P Rev Med Suisse; 2008 Jul; 4(165):1661-5. PubMed ID: 18767292 [TBL] [Abstract][Full Text] [Related]
5. Off licence and off label prescribing in children: litigation fears for physicians. Hill P Arch Dis Child; 2005 Feb; 90 Suppl 1(Suppl 1):i17-8. PubMed ID: 15665151 [TBL] [Abstract][Full Text] [Related]
6. 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use. Meadows WA; Hollowell BD Int J Impot Res; 2008; 20(2):135-44. PubMed ID: 18004389 [TBL] [Abstract][Full Text] [Related]
7. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liverpool Women's Hospital. Herring C; McManus A; Weeks A Int J Pharm Pract; 2010 Aug; 18(4):226-9. PubMed ID: 20636674 [TBL] [Abstract][Full Text] [Related]
8. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription. Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512 [TBL] [Abstract][Full Text] [Related]
9. Drug use in pregnancy and lactation. Ives TJ; Tepper RS Prim Care; 1990 Sep; 17(3):623-45. PubMed ID: 2236340 [TBL] [Abstract][Full Text] [Related]
10. Satisfaction with pharmacotherapy for approved and off-label indications--a Delphi study. Kos M; Wertheimer AI; Mrhar A Ann Pharmacother; 2005 Apr; 39(4):649-54. PubMed ID: 15755789 [TBL] [Abstract][Full Text] [Related]
15. Compounded medicines and 'off label' prescribing - a case for more guidance. Fois RA; Mewes BT; McLachlan AJ; Ramzan I Aust Fam Physician; 2009; 38(1-2):16-20. PubMed ID: 19283230 [TBL] [Abstract][Full Text] [Related]
16. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study. Vroom F; van Roon EN; van den Berg PB; Brouwers JR; de Jong-van den Berg LT Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):52-61. PubMed ID: 17948319 [TBL] [Abstract][Full Text] [Related]
17. Psychotropic medications and informed consent: a review. Frank B; Gupta S; McGlynn DJ Ann Clin Psychiatry; 2008; 20(2):87-95. PubMed ID: 18568580 [TBL] [Abstract][Full Text] [Related]
18. Check suitability, minimise sue-ability! Shakib S; George A Aust Fam Physician; 2003 Aug; 32(8):621-4. PubMed ID: 12973870 [TBL] [Abstract][Full Text] [Related]